Bis(6-(6-carboxylato-2-pyridinyl)pyridine-2-carboxylate);dysprosium(3+);triethylazanium;trihydrate
C30H34DyN5O11 — CID 139160513
Data last refreshed: (MolForge compound catalog, from PubChem)
About Bis(6-(6-carboxylato-2-pyridinyl)pyridine-2-carboxylate);dysprosium(3+);triethylazanium;trihydrate
Bis(6-(6-carboxylato-2-pyridinyl)pyridine-2-carboxylate);dysprosium(3+);triethylazanium;trihydrate (PubChem CID 139160513) has the molecular formula C30H34DyN5O11 and a molecular weight of 803.13 g/mol. Its IUPAC name is bis(6-(6-carboxylato-2-pyridinyl)pyridine-2-carboxylate);dysprosium(3+);triethylazanium;trihydrate.
Molecular Properties
| Compound Name | Bis(6-(6-carboxylato-2-pyridinyl)pyridine-2-carboxylate);dysprosium(3+);triethylazanium;trihydrate |
|---|---|
| PubChem CID | 139160513 |
| Molecular Formula | C30H34DyN5O11 |
| Molecular Weight | 803.13 g/mol |
| Exact Mass | 804.15 |
| IUPAC Name | bis(6-(6-carboxylato-2-pyridinyl)pyridine-2-carboxylate);dysprosium(3+);triethylazanium;trihydrate |
| SMILES | CC[NH+](CC)CC.O.O.O.O=C([O-])c1cccc(-c2cccc(C(=O)[O-])n2)n1.O=C([O-])c1cccc(-c2cccc(C(=O)[O-])n2)n1.[Dy+3] |
| InChI | InChI=1S/2C12H8N2O4.C6H15N.Dy.3H2O/c2*15-11(16)9-5-1-3-7(13-9)8-4-2-6-10(14-8)12(17)18;1-4-7(5-2)6-3;;;;/h2*1-6H,(H,15,16)(H,17,18);4-6H2,1-3H3;;3*1H2/q;;;+3;;;/p-3 |
| InChIKey | ZUZRBRLBWYZWGL-UHFFFAOYSA-K |
| XLogP | -4.80 |
| TPSA | 311.02 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 47 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 803.13 |
| LogP ≤ 5 | -4.80 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139160513 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.